{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:47:11Z","timestamp":1775890031492,"version":"3.50.1"},"reference-count":28,"publisher":"Massachusetts Medical Society","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2014,5,22]]},"DOI":"10.1056\/nejmoa1402338","type":"journal-article","created":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T13:01:09Z","timestamp":1399208469000},"page":"1983-1992","source":"Crossref","is-referenced-by-count":574,"title":["ABT-450\/r\u2013Ombitasvir and Dasabuvir with or without Ribavirin for HCV"],"prefix":"10.1056","volume":"370","author":[{"given":"Peter","family":"Ferenci","sequence":"first","affiliation":[]},{"given":"David","family":"Bernstein","sequence":"additional","affiliation":[]},{"given":"Jacob","family":"Lalezari","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Cohen","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[]},{"given":"Edward","family":"Tam","sequence":"additional","affiliation":[]},{"given":"Rui T.","family":"Marinho","sequence":"additional","affiliation":[]},{"given":"Naoky","family":"Tsai","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Nyberg","sequence":"additional","affiliation":[]},{"given":"Terry D.","family":"Box","sequence":"additional","affiliation":[]},{"given":"Ziad","family":"Younes","sequence":"additional","affiliation":[]},{"given":"Pedram","family":"Enayati","sequence":"additional","affiliation":[]},{"given":"Sinikka","family":"Green","sequence":"additional","affiliation":[]},{"given":"Yaacov","family":"Baruch","sequence":"additional","affiliation":[]},{"given":"Bal Raj","family":"Bhandari","sequence":"additional","affiliation":[]},{"given":"Florin Alexandru","family":"Caruntu","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Sepe","sequence":"additional","affiliation":[]},{"given":"Vladimir","family":"Chulanov","sequence":"additional","affiliation":[]},{"given":"Ewa","family":"Janczewska","sequence":"additional","affiliation":[]},{"given":"Giuliano","family":"Rizzardini","sequence":"additional","affiliation":[]},{"given":"Judit","family":"Gervain","sequence":"additional","affiliation":[]},{"given":"Ramon","family":"Planas","sequence":"additional","affiliation":[]},{"given":"Christophe","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Tarek","family":"Hassanein","sequence":"additional","affiliation":[]},{"given":"Wangang","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Martin","family":"King","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Podsadecki","sequence":"additional","affiliation":[]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[]}],"member":"150","reference":[{"key":"r001","unstructured":"Hepatitis C: fact sheet no. 164. Geneva: World Health Organization (http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en)."},{"key":"r002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1006613"},{"key":"r003","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"r004","unstructured":"Global Alert and Response (GAR): hepatitis C. Geneva: World Health Organization (http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/index2.html)."},{"key":"r005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"r006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"r007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806104"},{"key":"r008","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26641"},{"key":"r009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"r010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1113272"},{"key":"r011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807650"},{"key":"r012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.10.019"},{"key":"r013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01396.x"},{"key":"r014","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.055"},{"key":"r015","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23192"},{"key":"r016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213557"},{"key":"r017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104430"},{"key":"r018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306227"},{"key":"r019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"r020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62121-2"},{"key":"r021","first-page":"1","volume":"8","author":"Jacobson IM","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"r022","unstructured":"Menon RM, Klein CE, Lawal AA, et al. Pharmacokinetics and tolerability of the HCV protease inhibitor ABT-450 following single ascending doses in healthy adult volunteers with and without ritonavir. In: Program and abstracts of HepDART 2009, Kohala Coast, HI, December 6\u201310, 2009."},{"key":"r023","doi-asserted-by":"crossref","unstructured":"Pilot-Matias T, Koev G, Krishnan P, et al. In vitro combinatory effect of HCV NS3\/4A protease inhibitor ABT-450, NS5A inhibitor ABT-267, and non-nucleoside NS5B polymerase inhibitor ABT-333. In: Program and abstracts of the 47th Annual Meeting of the European Association for the Study of the Liver, Barcelona, April 18\u201322, 2012.","DOI":"10.1016\/S0168-8278(12)60879-4"},{"key":"r024","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014463"},{"key":"r025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"r026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402869"},{"key":"r027","unstructured":"Jacobson IM, Ghalib RH, Rodriguez-Torres M, et al. SVR results of a once-daily regimen of simeprevir (TMC435) plus sofosbuvir (GS-7977) with or without ribavirin in cirrhotic and non-cirrhotic HCV genotype 1 treatment-naive and prior null responder patients: the COSMOS study. In: Program and abstracts of the 64th Annual Meeting of the American Association for the Study of Liver Diseases, Washington, DC, November 1\u20135, 2013."},{"key":"r028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1402338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T03:02:15Z","timestamp":1565406135000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1402338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":28,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014,5,22]]}},"alternative-id":["10.1056\/NEJMoa1402338"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1402338","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}